Accessibility Menu
 
Onconetix logo

Onconetix

(NASDAQ) ONCO

Current Price$1.09
Market Cap$781,400
Since IPO (2022)-100%
5 YearN/A
1 Year-96%
1 Month-65%

Onconetix Financials at a Glance

Market Cap

$781,400

Revenue (TTM)

$815.37K

Net Income (TTM)

$14.03M

EPS (TTM)

$-264.05

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.09

Volume

13,093,764.908

Open

$1.30

Previous Close

$1.09

Daily Range

$1.01 - $1.36

52-Week Range

$1.01 - $74.29

ONCO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Onconetix

Industry

Biotechnology

Employees

8

CEO

Karina M. Fedasz, MBA, CPA

Headquarters

Cincinnati, OH 45202, US

ONCO Financials

Key Financial Metrics (TTM)

Gross Margin

78%

Operating Margin

-22%

Net Income Margin

-17%

Return on Equity

-110%

Return on Capital

-1%

Return on Assets

-56%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

-2.92%

Stock Overview

Market Cap

$781.40K

Shares Outstanding

716.80K

Volume

13.09M

Short Interest

0.00%

Avg. Volume

5.40M

Financials (TTM)

Gross Profit

$632.91K

Operating Income

$6.34M

EBITDA

$6.33M

Operating Cash Flow

$9.68M

Capital Expenditure

$0.00

Free Cash Flow

$9.68M

Cash & ST Invst.

$5.22M

Total Debt

$48.77K

Onconetix Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$303.60K

-57.4%

Gross Profit

$247.68K

-62.5%

Gross Margin

81.58%

N/A

Market Cap

$781.40K

N/A

Market Cap/Employee

$65.12K

N/A

Employees

12

N/A

Net Income

$5.67M

+119.3%

EBITDA

$1.28M

+95.7%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$5.17M

+158.8%

Accounts Receivable

$296.87K

+208.2%

Inventory

$149.96K

+134.0%

Long Term Debt

$24.36K

N/A

Short Term Debt

$24.41K

-99.7%

Return on Assets

-56.29%

N/A

Return on Invested Capital

-1.13%

N/A

Free Cash Flow

$3.09M

-235.4%

Operating Cash Flow

$3.09M

-236.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SCNIScinai Immunotherapeutics Ltd.
$0.58-1.64%
SLXNSilexion Therapeutics Ltd.
$1.05-5.41%
PTIXProtagenic Therapeutics, Inc.
$0.58-15.22%
ENVBEnveric Biosciences, Inc.
$1.96-3.71%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$128.06-0.02%
INTCIntel
$62.38+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.61+0.02%
CRWVCoreWeave
$102.00+0.11%

Questions About ONCO

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.